A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer

American Journal of Human Genetics

Volumn 91, Issue 2, 2012, Pages 384-390

  Liu, Bin ^a   Yang, Lei ^a   Huang, Binfang ^a   Cheng, Mei ^a   Wang, Hui ^a   Li, Yinyan ^a   Huang, Dongsheng ^a   Zheng, Jian ^b   Li, Qingchu ^a   Zhang, Xin ^a   Ji, Weidong ^a   Zhou, Yifeng ^b   Lu, Jiachun ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DNA COPY NUMBER VARIATIONS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; ODDS RATIO; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS;

EID: 84864944595     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2012.07.003     Document Type: Article

References (33)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J. Clin. 61 2011 212 236
2. M.R. Spitz, W.K. Hong, C.I. Amos, X. Wu, M.B. Schabath, Q. Dong, S. Shete, and C.J. Etzel A risk model for prediction of lung cancer J. Natl. Cancer Inst. 99 2007 715 726
3. J. Maruyama, I. Naguro, K. Takeda, and H. Ichijo Stress-activated MAP kinase cascades in cellular senescence Curr. Med. Chem. 16 2009 1229 1235
4. N. Ronkina, A. Kotlyarov, and M. Gaestel MK2 and MK3 - a pair of isoenzymes? Front. Biosci. 13 2008 5511 5521
5. W. ten Hove, L.A. Houben, J.A. Raaijmakers, M. Bracke, and L. Koenderman Differential regulation of TNFalpha and GM-CSF induced activation of P38 MAPK in neutrophils and eosinophils Mol. Immunol. 44 2007 2492 2496
6. R.M. Jackson, and R. Garcia-Rojas Kinase activity, heat shock protein 27 phosphorylation, and lung epithelial cell glutathione Exp. Lung Res. 34 2008 245 262
7. R.S. Stearman, L. Dwyer-Nield, L. Zerbe, S.A. Blaine, Z. Chan, P.A. Bunn Jr., G.L. Johnson, F.R. Hirsch, D.T. Merrick, and W.A. Franklin Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model Am. J. Pathol. 167 2005 1763 1775
8. L. Yang, Y. Li, M. Cheng, D. Huang, J. Zheng, B. Liu, X. Ling, Q. Li, X. Zhang, and W. Ji A functional polymorphism at microRNA-629-binding site in the 3′-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population Carcinogenesis 33 2012 338 347
9. B. Huang, B. Liu, L. Yang, Y. Li, M. Cheng, D. Huang, H. Wang, X. Zhang, J. Zheng, and Q. Li Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern chinese Int. J. Cancer 131 2012 E744 E758
10. J. Lu, L. Yang, H. Zhao, B. Liu, Y. Li, H. Wu, Q. Li, B. Zeng, Y. Wang, W. Ji, and Y. Zhou The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations Hum. Mutat. 32 2011 1299 1308
11. P. Mayo, T. Hartshorne, K. Li, C. McMunn-Gibson, K. Spencer, and N. Schnetz-Boutaud CNV analysis using TaqMan copy number assays Curr. Protoc. Hum. Genet. 67 2010 2.13.1-2.13.10
12. J.E. Eckel-Passow, E.J. Atkinson, S. Maharjan, S.L. Kardia, and M. de Andrade Software comparison for evaluating genomic copy number variation for Affymetrix 6.0 SNP array platform BMC Bioinformatics 12 2011 220
13. H. Akaike Information theory as an extension of the maximum likelihood principle B.N. Petrov, F. Csaki, Second International Symposium on Information Theory 1973 Akademiai Kiado Budapest 267 281
14. D. Gabeau-Lacet, D. Engler, S. Gupta, G.A. Scangas, R.A. Betensky, F.G. Barker 2nd, J.S. Loeffler, D.N. Louis, and G. Mohapatra Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome J. Neuropathol. Exp. Neurol. 68 2009 1155 1165
15. M. Jansen, G. Mohapatra, R.A. Betensky, C. Keohane, and D.N. Louis Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival Neuropathol. Appl. Neurobiol. 38 2012 213 219
16. M. Pomérance, J. Quillard, F. Chantoux, J. Young, and J.P. Blondeau High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms J. Pathol. 209 2006 298 306
17. G. Seisenbacher, E. Hafen, and H. Stocker MK2-dependent p38b signalling protects Drosophila hindgut enterocytes against JNK-induced apoptosis under chronic stress PLoS Genet. 7 2011 e1002168
18. Y. Li, K. Inoki, P. Vacratsis, and K.L. Guan The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3 J. Biol. Chem. 278 2003 13663 13671
19. S. Chakraborty, S.M. Mohiyuddin, K.S. Gopinath, and A. Kumar Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma BMC Cancer 8 2008 163
20. R. Wu, H. Kausar, P. Johnson, D.E. Montoya-Durango, M. Merchant, and M.J. Rane Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex J. Biol. Chem. 282 2007 21598 21608
21. I.A. Manke, A. Nguyen, D. Lim, M.Q. Stewart, A.E. Elia, and M.B. Yaffe MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation Mol. Cell 17 2005 37 48
22. J. Tang, X. Yang, and X. Liu Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression Oncogene 27 2008 6635 6645
23. H. Guo, Y. Bai, P. Xu, Z. Hu, L. Liu, F. Wang, G. Jin, F. Wang, Q. Deng, and Y. Tu Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival J. Clin. Oncol. 28 2010 1928 1935
24. S. Maitra, C.F. Chou, C.A. Luber, K.Y. Lee, M. Mann, and C.Y. Chen The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2 RNA 14 2008 950 959
25. N. Ronkina, M.B. Menon, J. Schwermann, C. Tiedje, E. Hitti, A. Kotlyarov, and M. Gaestel MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin Biochem. Pharmacol. 80 2010 1915 1920
26. M. Kobayashi, M. Nishita, T. Mishima, K. Ohashi, and K. Mizuno MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration EMBO J. 25 2006 713 726
27. H.C. Reinhardt, A.S. Aslanian, J.A. Lees, and M.B. Yaffe p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage Cancer Cell 11 2007 175 189
28. S.A. McCarroll, and D.M. Altshuler Copy-number variation and association studies of human disease Nat. Genet. 39 7, Suppl 2007 S37 S42
29. J.M. Chen, E. Masson, C. Le Maréchal, and C. Férec Copy number variations in chronic pancreatitis Cytogenet. Genome Res. 123 2008 102 107
30. R. Colobran, E. Pedrosa, L. Carretero-Iglesia, and M. Juan Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease Clin. Exp. Immunol. 162 2010 41 52
31. S.J. Diskin, C. Hou, J.T. Glessner, E.F. Attiyeh, M. Laudenslager, K. Bosse, K. Cole, Y.P. Mossé, A. Wood, and J.E. Lynch Copy number variation at 1q21.1 associated with neuroblastoma Nature 459 2009 987 991
32. L. Huang, D. Yu, C. Wu, K. Zhai, G. Jiang, G. Cao, C. Wang, Y. Liu, M. Sun, and Z. Li Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk Carcinogenesis 33 2012 94 100
33. A. Shlien, and D. Malkin Copy number variations and cancer susceptibility Curr. Opin. Oncol. 22 2010 55 63